psoriasis
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients with mild to moderate plaque psoriasis according to Western medical diagnostic criteria. (2)PASI score < 10 BSA < 10% DLQI < 10. (3)Patients with plaque psoriasis that according to Uighur medicine differentiation analysis meet the diagnosis of salty and mucous constitution. (4)Age between 18 and 65 years. (5)Informed consent and voluntary participation.
Exclusion criteria
Exclusion criteria: (1)Reverse psoriasis and mucosal psoriasis. (2)Patients with tuberculosis or cancer. (3)Patients with severe heart failure or severe primary diseases of the liver or kidneys (Note: ALT AST exceeding twice the upper limit of normal range; Cr exceeding the upper limit of normal range). (4)Use of corticosteroids or any psoriasis treatment medication within the past 2 weeks; and/or use of retinoids or topical corticosteroids or any topical psoriasis treatment medication within the past week. (5)Women planning to become pregnant currently pregnant or breastfeeding. (6)Suspected or confirmed history of alcohol or drug abuse. (7)Allergic individuals (allergic to more than 2 other drugs) or those allergic to any components of the medications in this study. (8)Other conditions that may reduce the likelihood of participation or complicate enrollment such as frequent changes in work environment mental disorders communication difficulties etc. as deemed inappropriate for participation by the investigator. (9)Participation in other drug clinical studies within the past month or currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| psoriasis area and severity index (PASI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-drug efficacy;Uighur Medicine Clinical Syndrome Score;Length of hospital stay;BSA Score; | — |
Countries
China
Contacts
Xinjiang Uyghur Autonomous Region Uyghur Medical Hospita Affiliation